Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for B6S7WD106 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Orin Hirschman
13G
|
14.5% |
6/22/2026
Event 6/10/2026
|
||
| Orin Hirschman | 14.5% | |||
| AIGH Capital Management LLC | 14.5% | |||
|
CVI Investments, Inc.
13G/A
|
9.9% |
8/14/2026
Event 6/30/2026
|
||
| CVI Investments, Inc. | 9.9% | |||
| Heights Capital Management, Inc. | 9.9% | |||
|
Cochlear Ltd
13D/A
|
5.9% |
6/11/2026
Event 6/10/2026
|
||
| Cochlear Investments Pty Ltd | 5.9% | |||
| Cochlear Limited | 5.9% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Vestal Point Capital, LP
13G/A
|
3.7% |
8/14/2025
Event 6/30/2025
|
||
| Vestal Point Capital, LP | 3.7% | |||
| Ryan Wilder | 3.7% | |||
| ResMed Inc. 13G/A | 2.0% |
7/1/2026
Event 6/30/2026
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 2.33 k | $3.21 k |
| 2026 Q2 | 45 | 22.1 M | $37.5 M |
| 2026 Q1 | 34 | 3.60 M | $10.4 M |
| 2025 Q4 | 33 | 3.71 M | $16.8 M |
| 2025 Q3 | 32 | 2.93 M | $13.5 M |
| 2025 Q2 | 32 | 3.90 M | $29.2 M |
| 2025 Q1 | 27 | 5.98 M | $41.8 M |
| 2024 Q4 | 23 | 6.78 M | $54.4 M |
| 2024 Q3 | 22 | 4.11 M | $39.1 M |
| 2024 Q2 | 25 | 4.35 M | $30.4 M |
| 2024 Q1 | 21 | 2.18 M | $29.3 M |
| 2023 Q4 | 19 | 2.34 M | $10.9 M |
| 2023 Q3 | 18 | 2.58 M | $18.2 M |
| 2023 Q2 | 17 | 2.64 M | $21.1 M |
| 2023 Q1 | 19 | 2.37 M | $17.6 M |
| 2022 Q4 | 19 | 2.65 M | $13.3 M |
| 2022 Q3 | 22 | 3.06 M | $19.3 M |
| 2022 Q2 | 24 | 3.20 M | $29.8 M |
| 2022 Q1 | 20 | 3.27 M | $62.7 M |
| 2021 Q4 | 16 | 2.68 M | $60.9 M |
| 2021 Q3 | 18 | 2.58 M | $75.1 M |
| 2021 Q2 | 1 | 191 k | $5.75 M |
| 2021 Q1 | 1 | 304 k | $7.18 M |
| 2020 Q4 | 1 | 296 k | $5.73 M |
| 2020 Q3 | 1 | 106 k | $2.44 M |